source
- Sanofi pays Regeneron $1 billion upfront to co-develop four early-stage immunology assetsSanofi has agreed to pay Regeneron an upfront fee of $1 billion to partner on four early‑stage immunology programs, a move intended to capture the success of their joint Dupixent antibody. Dupixen…
- Devoted Health secures $1.2 billion in new funding to fuel senior member growthDevoted Health, a Medicare Advantage insurer and medical group, announced a fresh capital injection of nearly $1.2 billion. The financing round includes a $555 million Series G investment along wi…